Two Sigma Investments’s Shuttle Pharmaceuticals SHPH Stock Holding History

Two Sigma Investments’s Portfolio SHPH Stock Details SHPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6	Closed	-$23.1K	–	3179
2022 Q4	$23.1K	Sell	6 -10	-63%	-$48.6K	﹤0.01%	2666
2022 Q3	$151K	Buy	+16	New	+$652K	﹤0.01%	2164

Other funds holding SHPH

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Two Sigma Investments's SHPH Position: Q1 2023 in Review

Two Sigma Investments sold out of Shuttle Pharmaceuticals (SHPH) in Q1 2023, closing a stake of 6 shares — an estimated $23.1K sold.

Two Sigma Investments first reported a position in SHPH in Q3 2022 and held it in 2 quarters. The position peaked at $151K in Q3 2022. 3 funds tracked by Wall St. Rank hold SHPH as of Q1 2023.

Two Sigma Investments reported no remaining Shuttle Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Two Sigma Investments sold 6 Shuttle Pharmaceuticals shares in Q1 2023, an estimated $23.1K.
Two Sigma Investments first reported a position in Shuttle Pharmaceuticals in Q3 2022 and held it in 2 quarters.
Two Sigma Investments's Shuttle Pharmaceuticals position peaked at $151K in Q3 2022.
3 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q1 2023.

Based on Two Sigma Investments's 13F filing for Q1 2023, filed 15 May 2023.